Rempex (a wholly owned subsidiary of Melinta Therapeutics, LLC)
2 clinical trials · Sponsor
◉ Watch Rempex (a wholly owned subsidiary of Melinta Therapeutics, LLC)
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Meropenem-Vaborbactam in Children With Complicated Urinary Tract Infection, Including Acute Pyelonephritis (NCT06672978) | Rempex (a wholly owned subsidiary of Melinta Therapeutics, LLC) | 2025-06-03 |
Track Rempex (a wholly owned subsidiary of Melinta Therapeutics, LLC) automatically
Every clearance here is in the API, with alerts when new ones post.